Neurological Institute Outcomes

In 2023, 885 patients with episodic migraine completed at least 1 questionnaire following treatment. Of the 261 patients who reported HIT-6 scores > 50 at initial evaluation, 28.7% reported improvement.¹ Of the 557 patients who reported initial PROMIS Global Health more than one-half standard deviation below the normative mean,² 84% improved or remained stable. Of the 484 patients who completed the PHQ-9 at six months follow-up and reported initial depressive symptoms above the cutoff of ≥ 10 points,³ 17.1% reported improvement of depressive symptoms on follow-up. Of the 287 patients who reported initial anxiety symptoms above the cutoff of ≥ 10 points,⁴ 20.6% reported improvement at follow-up.